Testing Viomes Condition-Based and Precision Nutrition Supplements for Improving Gastrointestinal Health in Adults Aged 25-75

What this Trial Is About

Researchers are studying gastrointestinal health in US residents who have gastrointestinal issues, focusing on irritable bowel syndrome IBS diagnosed by ROME IV criteria with specific symptom scores. The study evaluates the effects of Viome-designed condition-based supplements and the Viome Precision Nutrition Program compared to a placebo. This interventional trial aims to improve clinical outcomes related to gastrointestinal wellness over approximately four months. Participants are randomly assigned to one of three groups a placebo group receiving inert capsules, a group receiving Viomes condition-based supplements tailored to overall health conditions, and a group receiving the Viome Precision Nutrition Program based on microbiome sample results. Each group may receive nutritional supplements, dietary recommendations, and coaching. The study is direct-to-participant and does not involve clinical sites, with some participants using a mobile app to support participation. During the trial, participants complete surveys and follow nutritional guidance as assigned. Researchers monitor the efficacy of both the condition-based supplements and the precision nutrition program over about four months. Participants must adhere to study instructions and use the Viome app as needed. The study assesses symptom improvements and dietary adherence while ensuring safety and participant compliance throughout the trial period.

Viome Nutritional Programs to Improve Clinical Outcomes for Gastrointestinal Conditions